|
|
#1
08-26-2016, 07:51 AM
|
|||
|
|||
Lung cancer doctors eye Merck?s Keytruda over Bristol?s Opdivo
(Reuters) - Recent clinical trial results are likely to lead doctors to treat more patients who have a common form of Lung cancer with a Merck drug at the expense of a Bristol-Myers Squibb medication at least until more data emerges, oncologists and analysts say. ??????? ??????: Lung cancer doctors eye Merck?s Keytruda over Bristol?s Opdivo || ??????: ahlam1399 || ??????: اسم منتداك
|
 |
|
|
العرض العادي
